D02 Carcinoma in situ of middle ear and respiratory system
D02 is the ICD-10-CM code family for Carcinoma in situ of middle ear and respiratory system: 7 codes, 5 of which can lead a home health claim.
Codes in family
7
Can lead a claim
5
Cannot lead a claim
2
What CMS assigns to D02
5 of the 7 codes group to MMTA - Infectious Disease, Neoplasms, and Blood-Forming Diseases; 2 are assigned no clinical group. None of the 7 is assigned a comorbidity subgroup. 5 of the 7 can lead a claim.
Every code in D02
Descriptions are CDC’s FY2027 wording; where CMS’s grouper abbreviates one, its form is shown beneath.
| Code | Description | Primary position | Clinical group | Comorbidity subgroup |
|---|---|---|---|---|
| D02.0 | Carcinoma in situ of larynx | Can lead a claim | K | None |
| D02.1 | Carcinoma in situ of trachea | Can lead a claim | K | None |
| D02.2 Carcinoma in situ of bronchus and lung | ||||
| D02.20 | Carcinoma in situ of unspecified bronchus and lung | Cannot lead a claimPrincipal diagnosis not assigned to a clinical group | None | None |
| D02.21 | Carcinoma in situ of right bronchus and lung | Can lead a claim | K | None |
| D02.22 | Carcinoma in situ of left bronchus and lung | Can lead a claim | K | None |
| D02.3 | Carcinoma in situ of other parts of respiratory system | Can lead a claim | K | None |
| D02.4 | Carcinoma in situ of respiratory system, unspecified | Cannot lead a claimPrincipal diagnosis not assigned to a clinical group | None | None |
Sources: CMS HH PPS Grouper Software (opens in a new tab) v07.2.26, effective 2026-10-01, for the clinical group, comorbidity subgroup, code-first conventions and primary-position flags; CDC NCHS ICD-10-CM FY2027 (opens in a new tab) code descriptions for the family title and code wording. This is the crosswalk Medicare runs a claim through. Grouping also depends on admission source, timing, the OASIS functional items and the rest of the diagnosis list.